Source: Medical Buyer

Auromedics: AuroMedics Pharma Recalls Over 59000 Vials Of Antipsychotic Injection In US

Aurobindo Pharma arm AuroMedics Pharma LLC is recalling 59.5 thousand vials of antipsychotic Fluphenazine Decanoate injection USP 125mg/5mL, (5 mL multiple dose vial) from the US market, the USFDA said. AuroMedics...Read More

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Ronald F Quadrel's photo - CEO of Auromedics

CEO

Ronald F Quadrel

CEO Approval Rating

73/100

Read more